Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz(Roswell Park Comprehensive Cancer Center), Erik S. Knudsen(Roswell Park Comprehensive Cancer Center)
Cited by 1,146
Related Papers
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
|Endocrine Related Cancer|2011|299
Dual Mechanisms for the Inhibition of E2F Binding to RB by Cyclin-Dependent Kinase-Mediated RB Phosphorylation
|Molecular and Cellular Biology|1997|290
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
|Science|2019|238
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer
|Oncotarget|2014|211
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
|Journal of Clinical Investigation|2006|192